Effect of a cancer vaccine prepared by fusions of hepatocarcinoma cells with dendritic cells

Figure 5 The expression of CD80 in DC, being brown yellow, 3. 3 × 100

Figure 6 The expression of CD86 in DC, being brown yellow, 3. 3 × 100

Figure 7 The expression of CD54 in DC, being brown yellow, 3. 3 × 100

Figure 8 The expression of CD80 in DC-H₂₂, being brown yellow, 3. 3 × 100

Figure 9 The expression of CD86 in DC-H₂₂, being brown yellow, 3. 3 × 100

Figure 10 The expression of CD54 in DC-H₂₂, being brown yellow, 3. 3 × 100

Figure 1 H₂₂-DC growth curve.

Figure 2 Tumor mass of BALB/c mice on d14 after inoculation.

Figure 4 H₂₂-DC fusion cells under phase microscope. 5 × 40

Figure 11 Tumorigenecity assays in BALB/c mice on d 14 following DC-H₂₂ inoculation.

Figure 12 Tumorigenecity assays in BALB/c mice on d 14 following DC-H₂₂ inoculation.

Figure 13 Tumorigenecity assays in BALB/c mice on d 14 following DC-H₂₂ inoculation.

Figure 3 Influence on CTL cells of kill activity in vitro on d10 after inoculation.

Figure 14 Tumorigenecity assays in BALB/c mice on d 14 following DC-H₂₂ inoculation.